[HTML][HTML] Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions
C Chen, L Wang, B Han, L Qin, B Ying - Medicine, 2020 - ncbi.nlm.nih.gov
C Chen, L Wang, B Han, L Qin, B Ying
Medicine, 2020•ncbi.nlm.nih.govAutoimmune hemolytic anemia (AIHA) is a rare disease in which autoantibodies target red
blood cells (RBCs), leading to anemia that ranges from no symptoms to severe life-
threatening hemolysis. Little is known about the severity of anemia, blood transfusion
efficiency and risk of transfusion-related reactions among hospitalized AIHA patients,
especially in those with incompatible RBC transfusions.
blood cells (RBCs), leading to anemia that ranges from no symptoms to severe life-
threatening hemolysis. Little is known about the severity of anemia, blood transfusion
efficiency and risk of transfusion-related reactions among hospitalized AIHA patients,
especially in those with incompatible RBC transfusions.
Abstract
Autoimmune hemolytic anemia (AIHA) is a rare disease in which autoantibodies target red blood cells (RBCs), leading to anemia that ranges from no symptoms to severe life-threatening hemolysis. Little is known about the severity of anemia, blood transfusion efficiency and risk of transfusion-related reactions among hospitalized AIHA patients, especially in those with incompatible RBC transfusions.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果